Stay updated with breaking news from Ed Mathers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Board appointments following recent $95 million CAD Series C Financing Inversago Pharma Inc. ("Inversago"), a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse
Series C financing led by NEA Provides advancement of INV-202 Phase 2 clinical trial in Diabetic Kidney Disease in Q4 Inversago Pharma Inc. ("Inversago"), a clinical stage biotech company with a unique
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
/PRNewswire/ -- SpliceBio, a biotechnology company exploiting protein splicing to develop next generation gene therapies, today announced the completion of an...